StockData

PRF Technologies vs Talphera

PRFX and TLPH side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How PRFX and TLPH compare

PRF Technologies keeps more of each dollar of sales as profit, with a net margin of −29541% compared with −1507600% at Talphera.

PRF Technologies scores higher on the StockData Score (6 against 5 for Talphera), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricPRFXTLPH
Size and price
Market cap–$44.7M
Share price$0.695$0.861
Change, 1 year−85.1%−18.0%
Change, 5 years−99.9%−93.4%
Beta (5Y)3.631.19
Employees612
StockData Score
Total score6 (better)5
Valuation score00
Growth score00
Performance score1 (better)0
Health score55
Dividend score00
Valuation
P/S–44686×
P/B–3.1×
Growth
Revenue growth (TTM)–−96.3%
Revenue growth, 5Y average–−65.1%
Profitability
Gross margin−312%–
Operating margin−30129% (better)−1474700%
Net margin−29541% (better)−1507600%
FCF margin−23277%–
Return on equity−41.3% (better)−143%
Return on invested capital−87.0%–
Financial health
Debt / equity0.000.00
Current ratio5.07 (better)4.29
Altman Z-score–−24.02
Piotroski F-score45 (better)
Dividends and buybacks
Shareholder yield–0.00%
Ownership
Held by institutions24.5%54.4%
Held by insiders24.1%46.8%
Insider net buying, 12 months–$304K
Short interest, % of float2.0%4.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.